申请人:GlaxoSmithKline LLC
公开号:US07816395B2
公开(公告)日:2010-10-19
The present invention relates to a compound represented by the following formula:
or a pharmaceutically acceptable salt thereof, or a solvate thereof, or a combination thereof, wherein R1, R2, and X are as defined herein. Compounds of the present invention are useful as progesterone receptor modulators.
本发明涉及下列式子所代表的化合物:或其药学上可接受的盐、溶剂化物或其组合物,其中R1、R2和X的定义如本文所述。本发明的化合物可用作孕激素受体调节剂。